These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25234331)

  • 21. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
    Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
    J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.
    Heininger U; Braun-Fahrländer C; Desgrandchamps D; Glaus J; Grize L; Wutzler P; Schaad UB;
    Pediatr Infect Dis J; 2001 Aug; 20(8):775-8. PubMed ID: 11734740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
    Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
    Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
    Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus.
    Landry ML; Cohen SD; Mayo DR; Fong CK; Andiman WA
    J Clin Microbiol; 1987 May; 25(5):832-5. PubMed ID: 3034966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
    Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
    Sauerbrei A; Wutzler P
    Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of varicella-zoster virus in the German population.
    Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
    Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test].
    Liu JJ; Wang ML; Gan L; Liao WJ; Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Apr; 30(4):371-5. PubMed ID: 19731531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The seroepidemiology of varicella in Italy.
    Gabutti G; Penna C; Rossi M; Salmaso S; Rota MC; Bella A; Crovari P;
    Epidemiol Infect; 2001 Jun; 126(3):433-40. PubMed ID: 11467800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence rate after one dose of varicella vaccine in infants.
    Kim SH; Lee HJ; Park SE; Oh SH; Lee SY; Choi EH
    J Infect; 2010 Jul; 61(1):66-72. PubMed ID: 20380851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of varicella zoster antibodies among children with malnutrition, malignancies and HIV infection.
    Admani B; Macharia WM; Were F
    East Afr Med J; 2008 Oct; 85(10):480-6. PubMed ID: 19537424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand.
    Thongmee T; Chansaenroj J; Klinfueng S; Aeemjinda R; Wanlapakorn N; Poovorawan Y
    Hum Vaccin Immunother; 2024 Dec; 20(1):2367283. PubMed ID: 39051458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
    Lafer MM; de Moraes-Pinto MI; Weckx LY
    Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.
    Sauerbrei A; Schäfler A; Hofmann J; Schacke M; Gruhn B; Wutzler P
    Clin Vaccine Immunol; 2012 Aug; 19(8):1261-8. PubMed ID: 22718131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of antibodies to varicella-zoster virus using a virus-free fluorescent-antibody-to-membrane-antigen (FAMA) test.
    Park R; Hwang JY; Lee KI; Namkoong S; Choi SK; Park S; Park H; Park J
    J Microbiol Biotechnol; 2015 Feb; 25(2):268-73. PubMed ID: 25248983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.